RSN0402

· Shenzhen Resproly Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSN0402, covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers [Phase 1]